HeyJaredOff-Label With Altasciences
Off-Label presents candid conversations about the drug development industry from an insider perspective. We discuss trending topics and new developments alongside industry experts. Whether you’re drug development-curious or a seasoned veteran, enjoy as we peel back the label.
- Indexed episodes, last 90 days
- 1
- Latest publication
- Sep 15, 2026
- Audience
- Checking…
- Earliest in this view
- Sep 15, 2026
Latest episodes
EP5: The Business of Biotech: Science, Funding, and What Comes Next (opens the original)
Read excerpt
What does it really take to build a successfulbiotech? From addressing unmet medical needs, securing investor backing and reaching critical value inflection points, to navigating acquisitions and building a company positioned for long-term success, there’s a delicate balance to strike between science and finance. On the latest Off-Label With Altasciences , host Lisa Sanford is joined by James Mackay, President, Chief Executive Officer, and Co-Founder of Crystalys Therapeutics Inc., to unpack whe
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.